Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 377

1.

ESGO contribution to the WHO initiative on elimination of cervical cancer.

Gultekin M, Morice P, Concin N, Querleu D.

Int J Gynecol Cancer. 2020 Mar 2. pii: ijgc-2020-001286. doi: 10.1136/ijgc-2020-001286. [Epub ahead of print] No abstract available.

PMID:
32122949
2.

Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.

Fotopoulou C, Concin N, Planchamp F, Morice P, Vergote I, du Bois A, Querleu D.

Int J Gynecol Cancer. 2020 Feb 20. pii: ijgc-2020-001248. doi: 10.1136/ijgc-2020-001248. [Epub ahead of print] No abstract available.

PMID:
32086362
3.

Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.

Rychlik A, Angeles MA, Migliorelli F, Croce S, Mery E, Martinez A, Ferron G, Guyon F, Querleu D.

Int J Gynecol Cancer. 2020 Mar;30(3):358-363. doi: 10.1136/ijgc-2019-000904. Epub 2020 Jan 6.

PMID:
31911532
4.

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer.

Cibula D, Planchamp F, Fischerova D, Fotopoulou C, Kohler C, Landoni F, Mathevet P, Naik R, Ponce J, Raspagliesi F, Rodolakis A, Tamussino K, Taskiran C, Vergote I, Wimberger P, Zahl Eriksson AG, Querleu D.

Int J Gynecol Cancer. 2020 Jan;30(1):3-14. doi: 10.1136/ijgc-2019-000878.

PMID:
31900285
5.

The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.

Croce S, Lesluyes T, Valle C, M'Hamdi L, Thébault N, Pérot G, Stoeckle E, Noël JC, Fontanges Q, Devouassoux-Shisheboran M, Querleu D, Guyon F, Floquet A, Chakiba C, Mayeur L, Rebier F, MacGrogan GM, Soubeyran I, Le Guellec S, Chibon F.

Clin Cancer Res. 2020 Feb 15;26(4):855-861. doi: 10.1158/1078-0432.CCR-19-2891. Epub 2019 Dec 3.

PMID:
31796515
6.

Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement.

Querleu D, Cibula D, Concin N, Fagotti A, Ferrero A, Fotopoulou C, Knapp P, Kurdiani D, Ledermann JA, Mirza MR, Morice P, Ponce J, Van der Steen-Banasik E, Taskiran C, Wimberger P, Zalewski K, Sessa C.

Int J Gynecol Cancer. 2020 Jan;30(1):15. doi: 10.1136/ijgc-2019-000775. Epub 2019 Nov 27. No abstract available.

PMID:
31780565
7.

[Management of the nodal disease in vulvar cancers. The ESGO guidelines].

Querleu D, Rychlik A, Guyon F, Floquet A, Planchamp F.

Bull Cancer. 2019 Oct 2. pii: S0007-4551(19)30340-6. doi: 10.1016/j.bulcan.2019.06.010. [Epub ahead of print] Review. French.

PMID:
31586525
8.

Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey.

Urkmez E, Andac-Jones E, Cibula D, Querleu D, Halaska MJ, Driak D, Sehouli J, Grabowski JP, Inci G, Zalewski K, Minig L, Zorrero C, Sancı M, Alan M, Ledermann JA, Fotopoulou C, Gultekin M.

Int J Gynecol Cancer. 2019 Nov;29(9):1425-1430. doi: 10.1136/ijgc-2019-000567. Epub 2019 Aug 30. No abstract available.

PMID:
31473662
9.

Combined vaginal and laparoscopic approach for the surgical management of cervical cancer: a historic note.

Querleu D, Leblanc E.

Int J Gynecol Cancer. 2019 Sep;29(7):1228-1229. doi: 10.1136/ijgc-2019-000750. Epub 2019 Jul 27. No abstract available.

PMID:
31352364
10.

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Eur J Cancer. 2019 Jul;116:35-44. doi: 10.1016/j.ejca.2019.04.018. Epub 2019 Jun 3.

PMID:
31170563
11.

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.

Colombo N, Sessa C, Bois AD, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO–ESGO Ovarian Cancer Consensus Conference Working Group.

Int J Gynecol Cancer. 2019 May 2. pii: ijgc-2019-000308. doi: 10.1136/ijgc-2019-000308. [Epub ahead of print]

PMID:
31048403
12.

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO-ESGO Ovarian Cancer Consensus Conference Working Group.

Ann Oncol. 2019 May 1;30(5):672-705. doi: 10.1093/annonc/mdz062.

13.

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.

Croce S, Hostein I, Longacre TA, Mills AM, Pérot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, McCluggage WG.

Mod Pathol. 2019 Jul;32(7):1008-1022. doi: 10.1038/s41379-018-0184-6. Epub 2019 Mar 16.

PMID:
30877273
14.

Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer.

Chiva L, Cibula D, Querleu D.

N Engl J Med. 2019 Feb 21;380(8):793-4. doi: 10.1056/NEJMc1816590. No abstract available.

PMID:
30789679
15.

Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?

Voglimacci M, Gabiache E, Lusque A, Ferron G, Ducassou A, Querleu D, Motton S, Chantalat E, Courbon F, Martinez A.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1551-1559. doi: 10.1007/s00259-018-4219-5. Epub 2019 Feb 7.

PMID:
30729273
16.

Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.

Angeles MA, Baissas P, Leblanc E, Lusque A, Ferron G, Ducassou A, Martínez-Gómez C, Querleu D, Martinez A.

Int J Gynecol Cancer. 2019 Mar;29(3):480-486. doi: 10.1136/ijgc-2018-000168. Epub 2019 Feb 1.

PMID:
30712019
17.

[French joint recommendations Management for Epithelial Ovarian Cancer of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY endorsed by INCa. Strengths and weaknesses].

Lavoué V, Huchon C, Lécuru F, Querleu D, Touboul C, Daraï E.

Gynecol Obstet Fertil Senol. 2019 Feb;47(2):120-122. doi: 10.1016/j.gofs.2018.12.014. Epub 2019 Jan 26. French.

PMID:
30691975
18.

Revised FIGO staging for carcinoma of the cervix uteri.

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu HS, Ngan H, Mäenpää J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J.

Int J Gynaecol Obstet. 2019 Apr;145(1):129-135. doi: 10.1002/ijgo.12749. Epub 2019 Jan 17. Review. Erratum in: Int J Gynaecol Obstet. 2019 Nov;147(2):279-280.

PMID:
30656645
19.

A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).

Cibula D, Dusek J, Jarkovsky J, Dundr P, Querleu D, van der Zee A, Kucukmetin A, Kocian R.

Int J Gynecol Cancer. 2019 Jan;29(1):212-215. doi: 10.1136/ijgc-2018-000010.

PMID:
30640706
20.

Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists.

Casarin J, Multinu F, Abu-Rustum N, Cibula D, Cliby WA, Ghezzi F, Leitao M, Konishi I, Nam JH, Querleu D, Soliman PT, Yost KJ, Weaver AL, Mariani A, Glaser GE.

Int J Gynecol Cancer. 2019 Jan;29(1):60-67. doi: 10.1136/ijgc-2018-000020.

21.

GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangement.

Croce S, Lesluyes T, Delespaul L, Bonhomme B, Pérot G, Velasco V, Mayeur L, Rebier F, Ben Rejeb H, Guyon F, McCluggage WG, Floquet A, Querleu D, Chakiba C, Devouassoux-Shisheboran M, Mery E, Arnould L, Averous G, Soubeyran I, Le Guellec S, Chibon F.

Genes Chromosomes Cancer. 2019 Mar;58(3):155-163. doi: 10.1002/gcc.22694. Epub 2019 Jan 7.

PMID:
30350331
22.

Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jul 25:391. doi: 10.1007/s00428-018-2419-9. [Epub ahead of print]

PMID:
30043108
23.

Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, Glenn McCluggage W, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):937-938. doi: 10.1007/s00428-018-2380-7. Erratum in: Virchows Arch. 2018 Jul 25;:391.

PMID:
29789924
24.

Sensitive molecular detection of small nodal metastasis in uterine cervical cancer using HPV16-E6/CK19/MUC1 cancer biomarkers.

Samouëlian V, Mechtouf N, Leblanc E, Cardin GB, Lhotellier V, Querleu D, Révillion F, Rodier F.

Oncotarget. 2018 Apr 24;9(31):21641-21654. doi: 10.18632/oncotarget.24956. eCollection 2018 Apr 24.

25.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Radiother Oncol. 2018 Jun;127(3):404-416. doi: 10.1016/j.radonc.2018.03.003. Epub 2018 May 1.

PMID:
29728273
26.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4. Erratum in: Virchows Arch. 2018 May 23;:.

PMID:
29725757
27.

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR.

Int J Gynecol Cancer. 2018 May;28(4):641-655. doi: 10.1097/IGC.0000000000001216.

PMID:
29688967
28.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. French.

PMID:
29397916
29.

Fluorescence-guided surgery for cancer patients: a proof of concept study on human xenografts in mice and spontaneous tumors in pets.

Mery E, Golzio M, Guillermet S, Lanore D, Le Naour A, Thibault B, Tilkin-Mariamé AF, Bellard E, Delord JP, Querleu D, Ferron G, Couderc B.

Oncotarget. 2017 Nov 30;8(65):109559-109574. doi: 10.18632/oncotarget.22728. eCollection 2017 Dec 12.

30.

When and Who Should Perform Epithelial Ovarian Cancer Surgery?

Escayola C, Torrent JJ, Ferron G, Quenet F, Querleu D.

Int J Gynecol Cancer. 2018 Mar;28(3):594-599. doi: 10.1097/IGC.0000000000001188. Review.

PMID:
29303937
31.

Left Lateral Endosurgical Extraperitoneal Total Hysterectomy with Para-Aortic and Pelvic Lymphadenectomy: A Novel Approach for the Obese Patient with Endometrial Cancer.

Ferron G, De Santiago J, Querleu D, Martinez A, Angeles MA, Boulet B, Guyon F, Zapardiel I.

J Minim Invasive Gynecol. 2018 May - Jun;25(4):730-736. doi: 10.1016/j.jmig.2017.11.019. Epub 2017 Dec 8.

PMID:
29229578
32.

Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study.

Martinez A, Filleron T, Rouanet P, Méeus P, Lambaudie E, Classe JM, Foucher F, Narducci F, Gouy S, Guyon F, Marchal F, Jouve E, Colombo PE, Mourregot A, Rivoire M, Chopin N, Houvenaeghel G, Jaffre I, Leveque J, Lavoue V, Leblanc E, Morice P, Stoeckle E, Verheaghe JL, Querleu D, Ferron G.

Ann Surg Oncol. 2018 Feb;25(2):535-541. doi: 10.1245/s10434-017-6120-z. Epub 2017 Nov 20.

PMID:
29159738
33.

[Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)].

Querleu D, Darai E, Lecuru F, Rafii A, Chereau E, Collinet P, Crochet P, Marret H, Mery E, Thomas L, Villefranque V, Floquet A, Planchamp F.

Gynecol Obstet Fertil Senol. 2017 Dec;45(12):715-725. doi: 10.1016/j.gofs.2017.10.008. Epub 2017 Nov 11. Review. French.

PMID:
29132772
34.

Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers).

Colombo N, Creutzberg C, Querleu D, Barahona M, Sessa C; ESMO Guidelines Committee.

Ann Oncol. 2017 Jul 1;28(suppl_4):iv153-iv156. doi: 10.1093/annonc/mdx243. No abstract available.

35.

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, duBois A.

Int J Gynecol Cancer. 2017 Sep;27(7):1534-1542. doi: 10.1097/IGC.0000000000001041.

PMID:
30814245
36.

2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy.

Querleu D, Cibula D, Abu-Rustum NR.

Ann Surg Oncol. 2017 Oct;24(11):3406-3412. doi: 10.1245/s10434-017-6031-z. Epub 2017 Aug 7.

37.

Mise à jour 2016 des recommandations pour la pratique clinique de Nice/Saint-Paul-de-Vence dans le cancer de l’ovaire et du col de l’utérus à un stade avancé.

Joly F, Querleu D, Namer M, Pujade-Lauraine E.

Bull Cancer. 2017 May;104 Suppl 1:S1-S5. doi: 10.1016/S0007-4551(17)30156-X. French.

PMID:
28625310
38.

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.

Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, Mahner S, Mahantshetty U, Mirza M, Petersen C, Querleu D, Regauer S, Rob L, Rouzier R, Ulrikh E, van der Velden J, Vergote I, Woelber L, van der Zee AGJ.

Int J Gynecol Cancer. 2017 May;27(4):832-837. doi: 10.1097/IGC.0000000000000975.

PMID:
28441255
39.

European Surgical Education and Training in Gynecologic Oncology: The impact of an Accredited Fellowship.

Chiva LM, Mínguez J, Querleu D, Cibula D, du Bois A.

Int J Gynecol Cancer. 2017 May;27(4):819-825. doi: 10.1097/IGC.0000000000000942.

PMID:
28410284
40.

Total Infragastric Omentectomy Including the Vascular Perigastric Arcade in Patients With Advanced Serous Ovarian Tumors.

Cordeiro Vidal G, Croce S, Guyon F, Babin G, Querleu D.

Int J Gynecol Cancer. 2017 Feb;27(2):252-257. doi: 10.1097/IGC.0000000000000832.

PMID:
28114233
41.

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

Fotopoulou C, Sehouli J, Aletti G, Harter P, Mahner S, Querleu D, Chiva L, Gabra H, Colombo N, du Bois A.

J Clin Oncol. 2017 Feb 20;35(6):587-590. doi: 10.1200/JCO.2016.71.0723. Epub 2017 Jan 9. No abstract available.

42.

Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.

Cordeiro Vidal G, Babin G, Querleu D, Guyon F.

Gynecol Oncol. 2017 Jan;144(1):223-224. doi: 10.1016/j.ygyno.2016.10.030. Epub 2016 Nov 9.

PMID:
27836207
43.

[Surgical management of ovarian cancer: Trends in clinical practice].

Querleu D, Meurette J, Daraï E, Morice P, Planchamp F.

Bull Cancer. 2016 Nov;103(11):935-940. doi: 10.1016/j.bulcan.2016.09.013. Epub 2016 Oct 18. French.

PMID:
27769513
44.

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, du Bois A.

Int J Gynecol Cancer. 2016 Sep;26(7):1354-63. doi: 10.1097/IGC.0000000000000767.

PMID:
27648648
45.

Cost-Efficiency of Robotic Surgery.

Covens A, Köhler C, Nam JH, Naumann RW, Obermair A, Querleu D.

Int J Gynecol Cancer. 2016 Jul;26(6):992-3. doi: 10.1097/IGC.0000000000000747. No abstract available.

PMID:
27327148
46.

Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma.

Ahmed I, Karedath T, Andrews SS, Al-Azwani IK, Mohamoud YA, Querleu D, Rafii A, Malek JA.

Oncotarget. 2016 Jun 14;7(24):36366-36381. doi: 10.18632/oncotarget.8917.

47.

Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer.

Martinez A, Ngo C, Leblanc E, Gouy S, Luyckx M, Darai E, Classe JM, Guyon F, Pomel C, Ferron G, Filleron T, Querleu D.

Ann Surg Oncol. 2016 Aug;23(8):2515-21. doi: 10.1245/s10434-015-5069-z. Epub 2016 Mar 23.

PMID:
27008588
48.

Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.

Halabi NM, Martinez A, Al-Farsi H, Mery E, Puydenus L, Pujol P, Khalak HG, McLurcan C, Ferron G, Querleu D, Al-Azwani I, Al-Dous E, Mohamoud YA, Malek JA, Rafii A.

PLoS Genet. 2016 Feb 18;12(2):e1005892. doi: 10.1371/journal.pgen.1005892. eCollection 2016 Feb. No abstract available.

49.

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

Vidal F, Guerby P, Luyckx M, Haddad P, Stoeckle E, Morice P, Leblanc E, Lecuru F, Daraï E, Classe JM, Pomel C, Filleron T, Ferron G, Querleu D, Rafii A.

PLoS One. 2016 Jan 28;11(1):e0147787. doi: 10.1371/journal.pone.0147787. eCollection 2016.

50.

Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.

Halabi NM, Martinez A, Al-Farsi H, Mery E, Puydenus L, Pujol P, Khalak HG, McLurcan C, Ferron G, Querleu D, Al-Azwani I, Al-Dous E, Mohamoud YA, Malek JA, Rafii A.

PLoS Genet. 2016 Jan 6;12(1):e1005755. doi: 10.1371/journal.pgen.1005755. eCollection 2016 Jan. Erratum in: PLoS Genet. 2016 Feb;12(2):e1005892.

Supplemental Content

Loading ...
Support Center